PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.
about
Prostacyclin-dependent apoptosis mediated by PPAR deltaA cellular repressor of E1A-stimulated genes that inhibits activation by E2FProtein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signallingProliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disordersPhosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseExperimental therapies and ongoing clinical trials to slow down progression of ADPKDHeregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cellsInhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886Peroxisome proliferator-activated receptor beta regulates acyl-CoA synthetase 2 in reaggregated rat brain cell culturesExpression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidneyFunctional interaction of bZIP proteins and the large subunit of replication factor C in liver and adipose cellsCyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdeltaMitotic clonal expansion: a synchronous process required for adipogenesisDifferent functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes.Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Electrical activity regulates AChR gene expression via JNK, PKCzeta and Sp1 in skeletal chick muscle.Therapeutic Implications of PPARgamma in Human Osteosarcoma.Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.Rapid cellular turnover in adipose tissueOxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis.Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.Mechanisms of lipase maturation.Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation.Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment.Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytesA novel RNAi lethality rescue screen to identify regulators of adipogenesis.CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis.The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system.Telmisartan inhibits human urological cancer cell growth through early apoptosis.Regulation of adipocyte differentiation.DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.Krüppel-like family of transcription factors: an emerging new frontier in fat biology.Identification of Creb3l4 as an essential negative regulator of adipogenesisPPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?Controversy: PPARgamma as a target for treatment of colorectal cancer.Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
P2860
Q24291677-3ED0C759-E623-427D-B95D-DD4F00D47A4DQ24329027-8C4F0807-51E2-4E10-87B2-FE00C85E6C46Q24532278-AF82172C-4AFA-4531-9047-2EFF2520C08BQ24538593-12C49042-8132-48FB-8667-B9AB47D38E8BQ24627125-7B825708-C298-406E-B27A-5DC1AB7DEA6FQ27001230-5459D9E9-8277-4F25-BDA5-BD73E5CA5BADQ28146113-22CAB913-2E9D-4CB2-AAA6-57A546A64ED3Q28366307-5F74A991-974E-477E-A32D-8239D6489F07Q28377342-49369870-5B02-4233-97E9-A6F6F31B1845Q28377689-D802AB53-E3F0-4BC3-AFB8-F99C951DCA8FQ28581950-4C168A3C-62FB-4EDD-B811-AC83BA19CF44Q28587698-CB692085-47C8-438B-9325-EC0AB869E7A9Q28588756-2235F21B-CEAC-4E96-A6C4-ABF609897DC0Q30846886-3E1192A2-C3F1-428D-9B25-E434CBAF41E6Q30977623-B79FBE65-0C76-4FDC-B07A-CBFCE802598CQ31860680-2642A25A-28EF-4068-90F5-8C657C2FC26BQ33674615-A98466F6-49DF-43AF-A56E-06F8DDFB7427Q33780711-6CC7B47E-5738-4872-AD4F-ECEB6CC4BFDEQ33782620-C14DEC7C-2365-4D4C-97C1-97006C339F32Q33847015-101AE99B-DA9C-47BF-ACFE-6145EAB34FF4Q33886740-8449FC45-62CF-4213-BAE8-83594F69AF21Q33890290-DE151136-B43B-4543-95BD-E682F51EFC6AQ33904125-928B1604-19C9-465E-9287-DBBBA2739622Q33967843-B72AF9A6-F67F-4288-AB4C-132227867A94Q33967999-B3AF0DA6-3F8C-4699-B2BB-F5C88BC61422Q34007479-D845D8D8-6DE9-49B8-BA1C-D2BA3F7404B2Q34146459-FC8B478A-B59B-4BFB-AD58-7EC791FDEE1FQ34297060-8ED116EE-EAF3-4718-BDE4-A93E12E79957Q34327828-19FA0442-5DB5-4C14-BDD0-582CE6BCCACFQ34341080-BC9C27B1-2751-4F4A-BDC1-FE1CAC526D6EQ34418476-CC72171F-05D7-4871-818B-40F99D463B15Q34454568-E940A2F0-8C98-495B-9E01-12E18185CDD1Q34463194-55458497-C041-4CF0-803A-226199D5DD50Q34612945-2F851888-3965-47F9-AFB9-D2F6A940FADDQ34662297-544017EA-BA57-492E-A7AB-BBFD3A36DF33Q34722604-C6659FC2-1611-4F59-8B00-122E5A917412Q34744898-4F68B57E-C898-4BEC-A47F-F335A4148938Q34786102-60AC01C5-A150-4CDA-8849-F0D35583E5CAQ34806273-A47B9FB5-406E-41D5-9719-3E474EAC2B44Q35126551-8D77A4DE-20BA-4D71-AEDC-22C353AAD5E2
P2860
PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@ast
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@en
type
label
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@ast
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@en
prefLabel
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@ast
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@en
P2093
P2860
P356
P1433
P1476
PPARgamma induces cell cycle w ...... y via down-regulation of PP2A.
@en
P2093
P2860
P304
P356
10.1101/GAD.11.15.1987
P577
1997-08-01T00:00:00Z